Global HTA Evidence (Analysis) Lead, Global Access

  Global HTA Evidence (Analysis) Lead in Global Access The Global Access (GA) department at F. Hoffmann-La Roche, Ltd. based in Basel, Switzerland is seeking a Global HTA (Health Technology Assessment) Evidence Lead to join the Global HTA Evidence group. This position would report to a Global HTA Evidence Team Enabler.  As a Global HTA Evidence Lead in Global Access (GA) you will work with colleagues across the global organization (commercial and development) and local market access representatives to develop the HTA Evidence strategies and packages supporting decisions which determine access to Roche’s innovative offerings. You will collaborate to develop the evidence package used by payers and other Health Technology Assessment bodies to support both the pre-launch and launch stage of reimbursement process. In the pre-launch phase, you will work to identify evidence gaps and data sources, design and execute evidence generation plans, and conduct analyses to address molecule and disease area questions to inform access and the broader integrated business . You will also contribute to functional, cross-functional, enterprise-wide or external initiatives that shape our business and healthcare environments including the application of novel methodologies used to support HTA decision making. This requires a good understanding of integrated access strategies, integrated evidence plans,  healthcare environments, affiliate pricing & reimbursement needs, as well as strong scientific and technical expertise. You will need strong strategic, collaboration and communication skills, as well as a solution-driven and entrepreneurial mindset. This position is required to: 1. Have the ability to communicate clear integrated access evidence strategies and methodologies  and insights derived from evidence used within HTA to diverse audiences. This requires an understanding of the broader context and how evidence can impact access and broader commercialization strategies. 2. Collaborate with colleagues across the organization to provide expertise required for the preparation of evidentiary plans and their application within HTA / reimbursement dossiers. 3. Design and implement HTA evidentiary strategies: developing evidence to support HTA decision making including decision analytical models, network meta-analyses and/or the analysis of clinical trial data.  The role requires collaboration, as the candidate will be expected to work closely with colleagues across the organization ( Global Product Strategy, Product Development, and Countries, etc.)  to provide expertise used in the preparation of HTA / reimbursement dossiers as well as more broadly implement access and commercialization strategies. We are looking for a candidate with strong statistical expertise to add to our team. Your main responsibilities include: Provides input into the design of clinical development programs to ensure evidence needs for HTA are considered within the global development and commercialization strategies Ensures that all functional activities are strategically aligned with other functions within Global Access and the wider organization (affiliates, Product Development, commercial and others) Actively contributes to best practices and continuous improvement within the HTA Evidence Group Keeps up to date with changing HTA landscape and academic research areas to ensure that current access trends and methodologies are incorporated into evidentiary plans and strategies Lead or contribute to cross-functional sub-teams within an existing global matrix team [for higher levels] Builds and maintains relationships with relevant external health economic, statistics, HTA, and policy experts and contributes to the development of methodologies relevant for HTA and payer activities Plans and executes health economic and/or statistical analyses on clinical trial data and other relevant data sources consideration of the input/feedback from affiliates and global colleagues whilst adhering to industry best practices to support access decision making  Develops supportive technical documentation of economic and statistical analyses and supports interpretation of findings with appropriate communication methods Works closely with country-level affiliates to support statistical and health economics input used within their localized reimbursement applications  Who you are Masters or Doctoral level degree in health economics, epidemiology, statistics or a related field with a quantitative focus Expertise in at least one of MS Excel (with VBA), R, SAS, Python, WinBUGS, JAGS or other relevant statistical software Expertise in conducting network meta-analyses (NMA) and/or the application of evolving methodologies in health economic modelling Strong statistical expertise required 3 or more years’ with hands-on experience working in a consultancy, academic institution, HTA / reimbursement agency or pharmaceutical industry  Strong organization, planning and prioritization skills with an ability to meet tight deadlines Strong written and verbal communication skills in English Team player with a positive mind-set who can work effectively with all key stakeholders (including both local and global colleagues) Extensive knowledge of health technology assessment, clinical research and development methods, and international payer evidence requirements Track record of research publications and other research outputs of high quality is beneficial Previous experience working with evidence to support HTA and market access decision making Do you have any questions? Please check our FAQs and videos on careers.roche.ch/faq.   Job Level:Manager without direct reports This employer is a corporate member of myGwork - LGBTQ+ professionals, the business community for LGBTQ+ professionals, students, inclusive employers & anyone who believes in workplace equality.